Coca-Cola Q4 2025 Earnings Miss Revenue Forecast

Coca-Cola Q4 2025 earnings missed revenue expectations as gains were offset by a $960 million BODYARMOR impairment, raising scrutiny of guidance.

February 10, 2026·2 min read
View all news articles
Centered flat vector soda bottle cluster with dimming glow evoking Coca-Cola Q4 2025 earnings miss and BODYARMOR impairment.

KEY TAKEAWAYS

  • Q4 net revenue was $11.8 billion, missing roughly $12.1 billion consensus.
  • Unit-case volume rose 2% while organic revenue grew 5% on concentrate and price/mix.
  • Operating income fell 32% after a $960 million noncash BODYARMOR trademark impairment.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Coca‑Cola’s Q4 2025 earnings, reported Feb. 10, 2026, showed revenue below expectations despite gains in unit-case volumes and price/mix. The company said a trademark impairment related to BODYARMOR reduced operating income.

Quarter Results and Impairment

Coca‑Cola Co. (KO) reported Q4 net revenues of $11.8 billion, up 2% year-over-year. Organic revenue, a non-GAAP measure excluding currency and acquisitions, rose 5%, driven by 4% growth in concentrate sales and a 1% price/mix increase. The revenue fell short of the roughly $12.05 billion consensus, the company said in its earnings release.

Unit-case volume grew 2%, led by Trademark Coca‑Cola and sparkling flavors. Juice, dairy, and plant-based volumes declined 3%, while water, sports, coffee, and tea rose 3%. Sparkling volumes were flat.

Reported Q4 earnings per share (EPS) rose 4% to $0.53. Comparable EPS, excluding certain items, increased 6% to $0.58, despite a nine-percentage-point currency headwind.

Operating income fell 32% after the company recorded a $960 million non-cash trademark impairment tied to BODYARMOR, detailed in its 8-K filing.

Fiscal Results and 2026 Outlook

For fiscal 2025, net revenues totaled $47.9 billion, up 2% year-over-year, with organic revenue growing 5%. Operating income rose 38% to $13.8 billion, producing a 28.7% margin. Reported EPS was $3.04, up 23%, while comparable EPS increased 4% to $3.00, reflecting an eight-percentage-point currency headwind.

Cash flow from operations was $7.4 billion, and free cash flow, a non-GAAP measure of cash available after capital expenditures, was $5.3 billion.

For fiscal 2026, the company forecasts organic revenue growth of 4% to 5% and expects about $12.2 billion in free cash flow. This guidance excludes an estimated 8% to 11% currency headwind, assumes the Coca‑Cola Beverages Africa sale will close in the second half of 2026 pending regulatory approvals, and anticipates roughly a one-percentage-point headwind from acquisitions and divestitures. The company presented this outlook as its baseline for comparability and cash-generation expectations next year.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

AstraZeneca Earnings Signal Next-Year Growth

AstraZeneca Earnings Signal Next-Year Growth

AstraZeneca earnings showed $58.7 billion in annual revenue and issued guidance that gives traders a peg for positioning around oncology readouts.

Transocean to Acquire Valaris

Transocean to Acquire Valaris

Transocean to Acquire Valaris in an all-stock deal, creating scale with a $10 billion backlog and synergies that shift investor positioning on deleveraging.

On Semiconductor Earnings Show Q4 Revenue Decline

On Semiconductor Earnings Show Q4 Revenue Decline

On Semiconductor Earnings reported Q4 revenue weakness and issued cautious Q1 2026 guidance, a mix that may pressure near-term share positioning and flows.

Kyndryl Stock Drops After 10-Q Delay And CFO Exit

Kyndryl Stock Drops After 10-Q Delay And CFO Exit

Kyndryl stock fell after a delayed SEC filing, disclosure of internal-controls weaknesses, a guidance cut and an interim CFO, sparking investor selling.

Workday CEO Change Brings Bhusri Back

Workday CEO Change Brings Bhusri Back

Workday CEO change returned Aneel Bhusri as CEO and reaffirmed FY2026 outlook, prompting investor selling ahead of upcoming results.

Oracle Stock Upgrade Spurs Funding Rethink

Oracle Stock Upgrade Spurs Funding Rethink

DA Davidson's Feb. 9 upgrade and a $25B bond sale refocused attention on an Oracle stock upgrade, narrowing funding overhang and aiding cloud re-rating.